Subcommittee approves bill to allow over‑the‑counter ivermectin sales for adults

A Medical and Health Affairs subcommittee voted unanimously to advance House Bill 4042 as amended, a measure that would permit adults 18 and older to purchase human‑grade ivermectin over the counter in this state.

The bill, as amended, directs the state board of pharmacy to establish standard dispensing procedures that include a screening risk assessment, patient information on indications and contraindications, and counseling on dosage and follow‑up care. The amendment also creates immunity for pharmacists acting in good faith and with reasonable care from disciplinary actions and civil liability except in cases of gross negligence or willful misconduct, and specifies that insurers would not be required to cover ivermectin dispensed under the statute.

"Ivermectin has been an FDA approved drug since 1996," said Dr. Alyssa Gulliamo in testimony supporting the bill, adding that clinical data show common side effects such as itching, dizziness and nausea typically affect "1 to 10 percent of users." She listed Tennessee, Arkansas, Idaho, Louisiana and Texas as states that have enacted nonprescription pathways for human ivermectin.

Sponsor Representative Jay Kilmartin said the amendment addresses pharmacist liability concerns by adding counseling and screening. He argued the change would improve access and lower cost, saying, "it's only a few cents a pill." A committee member questioned the need for state action because ivermectin can be obtained online; the sponsor responded that online purchases can take weeks and that local pharmacy access matters for timely treatment.

The amendment and the bill as amended passed on roll calls recorded in the hearing (recorded 'Aye' by Mister Beach, Miss Davis, Mister Montgomery and Mister Sessions). The subcommittee did not record any 'No' votes. The measure will move to the full committee/floor for further consideration.

Supporters pointed to state precedents where similar policies are in place; testimony and amendment language emphasized pharmacist counseling and safety protocols. Opponents were not recorded in the subcommittee hearing; questions focused on formulation differences and the availability of ivermectin through online vendors.

Next steps: HB4042 will proceed to the full House floor process according to legislative procedure.